Haque, S., Jawed, A., Akhter, N., Dar, S.A., Khan, F., Mandal, R.K., Areeshi, M.Y., Lohani, M. and Wahid, M. (2020) Acetylsalicylic Acid (Aspirin): A Potent Medicine for Preventing COVID-19 Deaths Caused by Thrombosis and Pulmonary Embolism. European Review for Medical and Pharmacological Sciences, 24, 9244-9245.

has been cited by the following article:

• TITLE: Changes in the Physical and Mechanical Properties of Human Blood with Sustained Prophylactic Use of Acetylsalicylic Acid (Aspirin)—A Rheological Study

  AUTHORS: Trevor Corrigan, Liam O’Malley, Dorian Bailey, Hope Moseley, Jada Okaikoi, Thomas Brown, Sean Murray, William Chang, Minseo Yang, Lam Nguyen, Erin Milner, Kevin O’Donovan, Matthew Armstrong

  KEYWORDS: Hemorheology, Rouleaux

  JOURNAL NAME: Open Journal of Fluid Dynamics, Vol.11 No.4, November 11, 2021

  ABSTRACT: While the prophylactic use of regular, low dosage, acetylsalicylic acid (aspirin) has been employed due to the inhibitory effect on platelet aggregation, few if any rheological studies validate the change in the physical and mechanical properties of human blood post-aspirin administration. The viscosity and yield stress of blood from eleven donors were assessed at varied shear rates before and after daily aspirin administration (81 mg) for 14 consecutive days. The findings indicate a statistically relevant aggregated decrease with respect to viscosity and yield stress within the study population.